{"schema_version":"secwatch.filing_event.v1","accession":"0001746473-26-000046","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2026-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.062418+00:00","generated_at":"2026-05-15T08:24:45.416824+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pliant Therapeutics enters $50M at-the-market equity facility with Leerink; terminates prior Cantor agreement","bullets":["Entered Sales Agreement with Leerink Partners for ATM offering of common stock up to $50 million.","Terminated 2021 Sales Agreement with Cantor Fitzgerald; no penalties incurred and no shares had been sold under it.","New ATM program provides continued market-based equity financing flexibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001746473-26-000046","json":"https://secwatch.observer/filing/0001746473-26-000046.json","markdown":"https://secwatch.observer/filing/0001746473-26-000046.md","text":"https://secwatch.observer/filing/0001746473-26-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/0001746473-26-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/plrx-20260327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:24:45.416824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}